GT Biopharma, Inc.
GTBP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,114 | -$1,433 | -$776 | -$3,775 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $7 | $0 | $8 |
| Change in WC | -$710 | -$545 | -$1,303 | $60 |
| Other Non-Cash | $147 | -$1,043 | -$123 | $1,239 |
| Operating Cash Flow | -$3,677 | -$3,014 | -$2,202 | -$2,468 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $7,859 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$5,034 |
| Other Inv. Act. | $0 | $0 | $0 | -$2,824 |
| Investing Cash Flow | $0 | $0 | $0 | $1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1,062 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$85 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $5,877 | $616 | $0 |
| Financing Cash Flow | $977 | $5,877 | $616 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,700 | $2,863 | -$1,586 | -$2,467 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,321 | $2,458 | $4,044 | $6,511 |
| End Cash | $2,621 | $5,321 | $2,458 | $4,044 |
| Free Cash Flow | -$3,677 | -$3,014 | -$2,202 | -$2,468 |